Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2020 | Allogeneic hemopoietic stem cell transplants for advanced phase CML

Elena Morozova • 30 Nov 2020
ASH 2020
Chronic Myeloid Leukemia Leukemia

Elena Morozova, MD, PhD, RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation, discusses the clinical need and challenges of performing allogeneic hemopoietic stem cell transplants (allo-HSCT) in patients with advanced phase chronic myeloid leukemia (CML). Dr Morozova goes on to highlight the findings of a comparative study in which patients that received allo-HSCT had significantly improved four-year overall survival (OS) as compared to the non-transplanted group. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals